SCHEMBL15535962

SCHEMBL15535962

CCOC(c1ccc(Cl)cc1)C1CCN(C(=O)O)CC1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.57
SLC6A4 P31645 4/20 0.57
SLC6A3 Q01959 3/20 0.57
FPR2 P25090 2/20 0.53
PROKR1 Q8TCW9 2/20 0.53
OPRD1 P41143 1/20 0.44
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.42
CACNA2D1 P54289 1/20 0.42
CACNA1B Q00975 1/20 0.42
CACNB1 Q02641 1/20 0.42
CACNA1C Q13936 1/20 0.42
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
FFAR1 O14842 1/20 0.39
TSHR P16473 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3405447 0.87 KDM4E (0.47) SLC6A2SLC6A4SLC6A3FPR2PROKR1
SCHEMBL15537475 0.86 SLC6A4 (0.52) SLC6A2SLC6A4SLC6A3FPR2PROKR1
SCHEMBL15536845 0.84 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3FPR2PROKR1
SCHEMBL15536002 0.77 FPR2 (0.47) FPR2PROKR1OPRD1KDM4ECACNA2D1
SCHEMBL16657611 0.76 SLC6A4 (0.73) SLC6A2SLC6A4SLC6A3FPR2PROKR1
SCHEMBL4072569 0.76 OPRD1 (0.46) OPRD1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL10335593 0.75 SLC6A4 (0.47) SLC6A2SLC6A4SLC6A3FPR2PROKR1
SCHEMBL23211957 0.73 CACNA1B (0.42) SLC6A3CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL21381670 0.73 CACNA1B (0.42) SLC6A3CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL7086566 0.73 FPR2 (0.50) FPR2PROKR1ALDH1A1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855449-A1 SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed
WO-2013179024-A1 SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-12-05 WO disclosed